Unraveling the role of hyaluronic acid on the targeting of vinorelbine-loaded NLC for lung cancer
Authors/Creators
- 1. University of Kufa, Faculty of Pharmacy, Department of Pharmaceutics
Contributors
Supervisors:
- 1. Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
- 2. Department of Pharmaceutics, College of Pharmacy, Al-Farahidi University, Baghdad, Iraq
Description
Hyaluronic acid (HA) is a naturally occurring mucopolysaccharide that exhibits specific interactions with overexpressed receptors on cancer cells, including CD44, RHAMM, and LYVE-1, facilitating targeted drug delivery to tumors. The present study aims to develop an activated nanostructured lipid carrier (NLC) functionalized with HA as a ligand to improve the selectivity and safety of parenterally administered vinorelbine (Vn). The findings indicate that HA-functionalized NLCs effectively enhanced the selective targeting and accumulation of vinorelbine within tumor tissue, prolonging its retention time and potentiating its cytotoxic effects. Additionally, the observed increase in mice body weight suggests an improved safety profile of the formulation
Files
Restricted
The record is publicly accessible, but files are restricted to users with access.
Additional details
Additional titles
- Alternative title (En)
- The role of hyaluronic acid on the targeting